JAISIM SHAH

CIK 1242133 · See Remarks · last filed 2024-12-18

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$50.3K

Companies

3

Total Filings

29

Lifetime Open-Market Net

-$670.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SCLXW See Remarks 295,215 $0.17 $50.2K $197.2K 8 2024-12-18
SRNE Director 178,075 $0.00 $89 $399.7K 16 2021-08-30
PDL BIOPHARMA, INC. (PDLI) Delisted SVP, Mktg & Bus. Affairs 15,812 -$1.27M 5 2008-04-30

Recent Filings · Page 2 of 3

29 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-04-23 SRNE Grant (A) $0 EDGAR
2018-11-27 SRNE Grant (A) $0 EDGAR
2017-09-18 SRNE Grant (A) $0 EDGAR
2017-09-15 SRNE Grant (A) $0 EDGAR
2017-06-15 SRNE Buy (P) +10,002 $17.9K EDGAR
2017-02-03 SRNE Buy (P) +10,000 $51.5K EDGAR
2016-07-12 SRNE Grant (A) $0 EDGAR
2015-08-05 SRNE Buy (P) +27,189 $312.7K EDGAR
2015-06-08 SRNE Grant (A) $0 EDGAR
2015-02-26 SRNE Grant (A) $0 EDGAR
Showing 1120 of 29
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.